Trifluridine/Tipiracil Combined With Oxaliplatin and Bevacizumab Versus XELOX Plus Bevacizumab in mCRC

Clinical trial NCT05077839 · UNKNOWN

Trial details

NCT number: NCT05077839
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

First-line Treatment Advanced Colorectal Cancer

Start date: 2021-09-01
Primary completion: 2024-08-31
Enrollment: 184

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.